{"id":1876,"date":"2024-03-27T13:37:22","date_gmt":"2024-03-27T13:37:22","guid":{"rendered":"https:\/\/stoxpo.com\/?p=1876"},"modified":"2024-03-27T13:37:23","modified_gmt":"2024-03-27T13:37:23","slug":"moderna-unveils-promising-new-vaccine-candidates-beyond-covid","status":"publish","type":"post","link":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/","title":{"rendered":"Moderna Unveils Promising New Vaccine Candidates Beyond COVID"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\">Breakthrough Clinical Trial Data Sets Stage for Diversified Product Portfolio<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Moderna (MRNA), the pioneering biotech company known for its COVID vaccine, is stepping into a new era of vaccine development with the announcement of positive clinical trial data on three experimental vaccines. This pivotal move signals Moderna&#8217;s strategic expansion beyond COVID and positions the company to address a range of infectious diseases. The latest breakthrough brings Moderna closer to achieving its vision of a diversified product portfolio and underscores its commitment to advancing public health worldwide.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The three experimental vaccines, targeting norovirus, Epstein-Barr virus, and Varicella-Zoster virus, have shown promising results in early-stage trials, demonstrating strong immune responses and favorable safety profiles. With potential applications spanning from preventing stomach flu to reducing the risk of cancer-associated viruses, these vaccine candidates represent significant opportunities for Moderna to address critical unmet medical needs.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Moderna&#8217;s success in advancing these vaccines reflects the company&#8217;s relentless pursuit of innovation and its commitment to leveraging mRNA technology to combat a wide range of infectious diseases. As Moderna continues to progress its pipeline of vaccine candidates, it reinforces its position as a leading force in vaccine development, poised to make a profound impact on global public health.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Read originial press release:<a href=\"https:\/\/www.accesswire.com\/847245\/moderna-advances-multiple-vaccine-programs-to-late-stage-clinical-trials\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">here<\/mark><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You might like this article:<a href=\"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/kulr-technology-fortifies-defense-sector-with-lockheed-martin-partnership\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">KULR Technology Fortifies Defense Sector with Lockheed Martin Partnership<\/mark><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Breakthrough Clinical Trial Data Sets Stage for Diversified Product Portfolio Moderna (MRNA), the pioneering biotech company known for its COVID vaccine, is stepping into a new era of vaccine development with the announcement of positive clinical trial data on three experimental vaccines. This pivotal move signals Moderna&#8217;s strategic expansion beyond COVID and positions the company [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1412,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"format":"standard"},"jnews_primary_category":[],"jnews_social_meta":[],"jnews_override_counter":[],"jnews_post_split":[],"footnotes":""},"categories":[308,361],"tags":[],"coauthors":[453],"class_list":["post-1876","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","category-large-cap"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Moderna Unveils Promising New Vaccine Candidates Beyond COVID - Stoxpo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Moderna Unveils Promising New Vaccine Candidates Beyond COVID - Stoxpo\" \/>\n<meta property=\"og:description\" content=\"Breakthrough Clinical Trial Data Sets Stage for Diversified Product Portfolio Moderna (MRNA), the pioneering biotech company known for its COVID vaccine, is stepping into a new era of vaccine development with the announcement of positive clinical trial data on three experimental vaccines. This pivotal move signals Moderna&#8217;s strategic expansion beyond COVID and positions the company [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/\" \/>\n<meta property=\"og:site_name\" content=\"Stoxpo\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-27T13:37:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-27T13:37:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mufid-majnun-9240711-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Liliana Vida\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Liliana Vida\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\\\/\"},\"author\":{\"name\":\"Liliana Vida\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\"},\"headline\":\"Moderna Unveils Promising New Vaccine Candidates Beyond COVID\",\"datePublished\":\"2024-03-27T13:37:22+00:00\",\"dateModified\":\"2024-03-27T13:37:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\\\/\"},\"wordCount\":230,\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mufid-majnun-9240711-scaled.jpg\",\"articleSection\":[\"Biotechnology\",\"Large-Cap\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\\\/\",\"name\":\"Moderna Unveils Promising New Vaccine Candidates Beyond COVID - Stoxpo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mufid-majnun-9240711-scaled.jpg\",\"datePublished\":\"2024-03-27T13:37:22+00:00\",\"dateModified\":\"2024-03-27T13:37:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mufid-majnun-9240711-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mufid-majnun-9240711-scaled.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"moderna-vaccine-2\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stoxpo.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Moderna Unveils Promising New Vaccine Candidates Beyond COVID\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"name\":\"Stoxpo\",\"description\":\"Stock Market &amp; Financial News\",\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stoxpo.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\",\"name\":\"Stoxpo\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"width\":250,\"height\":250,\"caption\":\"Stoxpo\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\",\"name\":\"Liliana Vida\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"caption\":\"Liliana Vida\"},\"description\":\"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/author\\\/stoxpo-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Moderna Unveils Promising New Vaccine Candidates Beyond COVID - Stoxpo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/","og_locale":"en_US","og_type":"article","og_title":"Moderna Unveils Promising New Vaccine Candidates Beyond COVID - Stoxpo","og_description":"Breakthrough Clinical Trial Data Sets Stage for Diversified Product Portfolio Moderna (MRNA), the pioneering biotech company known for its COVID vaccine, is stepping into a new era of vaccine development with the announcement of positive clinical trial data on three experimental vaccines. This pivotal move signals Moderna&#8217;s strategic expansion beyond COVID and positions the company [&hellip;]","og_url":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/","og_site_name":"Stoxpo","article_published_time":"2024-03-27T13:37:22+00:00","article_modified_time":"2024-03-27T13:37:23+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mufid-majnun-9240711-scaled.jpg","type":"image\/jpeg"}],"author":"Liliana Vida","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Liliana Vida","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/#article","isPartOf":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/"},"author":{"name":"Liliana Vida","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1"},"headline":"Moderna Unveils Promising New Vaccine Candidates Beyond COVID","datePublished":"2024-03-27T13:37:22+00:00","dateModified":"2024-03-27T13:37:23+00:00","mainEntityOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/"},"wordCount":230,"publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mufid-majnun-9240711-scaled.jpg","articleSection":["Biotechnology","Large-Cap"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/","url":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/","name":"Moderna Unveils Promising New Vaccine Candidates Beyond COVID - Stoxpo","isPartOf":{"@id":"https:\/\/stoxpo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/#primaryimage"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mufid-majnun-9240711-scaled.jpg","datePublished":"2024-03-27T13:37:22+00:00","dateModified":"2024-03-27T13:37:23+00:00","breadcrumb":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/#primaryimage","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mufid-majnun-9240711-scaled.jpg","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mufid-majnun-9240711-scaled.jpg","width":2560,"height":1707,"caption":"moderna-vaccine-2"},{"@type":"BreadcrumbList","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stoxpo.com\/"},{"@type":"ListItem","position":2,"name":"Moderna Unveils Promising New Vaccine Candidates Beyond COVID"}]},{"@type":"WebSite","@id":"https:\/\/stoxpo.com\/#website","url":"https:\/\/stoxpo.com\/","name":"Stoxpo","description":"Stock Market &amp; Financial News","publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stoxpo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stoxpo.com\/#organization","name":"Stoxpo","url":"https:\/\/stoxpo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","width":250,"height":250,"caption":"Stoxpo"},"image":{"@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1","name":"Liliana Vida","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6","url":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","caption":"Liliana Vida"},"description":"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.","url":"https:\/\/stoxpo.com\/index.php\/author\/stoxpo-com\/"}]}},"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/1876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=1876"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/1876\/revisions"}],"predecessor-version":[{"id":1878,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/1876\/revisions\/1878"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/1412"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=1876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=1876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=1876"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=1876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}